Clinical Trial Update: Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study evaluating chemotherapy in combination with autologous cytokine-induced killer cell immunotherapy for non-small cell lung cancer and squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Autologous cytokine-induced killer cell immunotherapy (cytokine-induced killer cells)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non-small Cell Lung Cancer, Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED